Home
About
Overview
Sharing Data
ORCID
Help
History (51)
Bilirubin
Verapamil
Sentinel Lymph Node
Factor VIIa
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma.
See All 51 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma.
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma. N Engl J Med. 2022 02 17; 386(7):629-639.
View in:
PubMed
subject areas
Adult
Aged
Antineoplastic Agents, Immunological
Antineoplastic Combined Chemotherapy Protocols
Combined Modality Therapy
Female
Hematopoietic Stem Cell Transplantation
Humans
Immunotherapy, Adoptive
Lymphoma, Large B-Cell, Diffuse
Male
Middle Aged
Receptors, Antigen, T-Cell
Salvage Therapy
Transplantation, Autologous
authors with profiles
Michael Bishop